CompletedNot Applicable

Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience

Egypt80 participantsStarted 2022-06-01

Plain-language summary

Transcatheter closure of secundum atrial septal defects is widely approved worldwide, yet it still has multiple risks like perforation and radiation exposure. In this study, we proposed a modified rapid method for closure of secundum atrial septal defects, to avoid material manipulation inside your heart and decrease complication rate.

Who can participate

Age range3 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any patient with ostium secundum ASD \& RV volume overload Exclusion Criteria: * Any other type of atrial septal defects Any other associated congenital anomaly

What they're measuring

recording any complication during transcatheter secundum atrial septal defect closure

Timeframe: during the procedure

Trial details

NCT IDNCT06655935

SponsorEgyptian Biomedical Research Network

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2023-06-01

View on ClinicalTrials.gov More Atrial Septal Defect (ASD) trials